Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE In Northern-European ancestry populations, HFE gene C282Y mutations are relatively common (0.3%-0.6% rare homozygote prevalence) and associated with excessive iron absorption, fatigue, diabetes, arthritis, and liver disease, especially in men. 30657865

2019

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE In conclusion, cirrhosis in HFE p.C282Y homozygotes is significantly associated with age, diabetes, daily alcohol intake, and iron removed by phlebotomy, taking into account the effect of other variables. 30145563

2018

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study. 26771691

2016

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE CONCLUSIONS In nonscreening hemochromatosis probands with HFE C282Y homozygosity, a heritable factor(s) increases the risk of diabetes diagnosed before hemochromatosis. 23990522

2014

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE The C282Y variant was not significantly associated with diabetes risk. 22908207

2012

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE The mutation C282Y was not associated with diabetes or its chronic complications. 20097100

2011

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE We determined the prevalence of HFE mutations (C282Y and H63D) in the Tasmanian CF population and assessed the relationship to systemic iron stores, Pseudomonas aeruginosa infection, lung disease severity and prevalence of diabetes. 20199637

2010

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE All other common HFE genotypes--including C282Y-H63D compound heterozygosity--are not associated with significant biochemical and clinical expression in the absence of comorbid factors (e.g., alcohol, diabetes or steatohepatitis). 19072401

2008

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE The mean serum ferritin concentration was greater (P < 0.0001) in women with diabetes than in those without diabetes for HFE genotypes except C282Y/C282Y and C282Y/H63D. 16936157

2006

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE A meta-analysis of 4,245 case and 5,982 control subjects indicated a null association of C282Y with diabetes risk, whereas carriers of H63D or the compound heterozygotes had marginally increased risk (odds ratio [OR] 1.11 [95% CI 1.00-1.25] and 1.60 [0.99-2.60], respectively). 16306377

2005

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE Younger ages of onset of diabetes as well as a longer duration of the disease were detected in patients carrying at least one C282Y allele (p = 0.007). 15347835

2004

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE Allele frequencies of C282Y and H63D did not differ between diabetic and control groups nor among subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes. 12148086

2002

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE Different studies investigating the association of C282Y heterozygocity with morbidity have given conflicting results, as is exemplified by extrahepatic cancers, cardiovascular diseases, alcoholic liver disease, and diabetes. 12324192

2002

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE In patients with clinical hemochromatosis, the frequency of diabetes ranges from 20 to 50%, and the heterozygosity for the C282Y mutation in the HFE gene might be associated with an increased risk for diabetes. 11423500

2001

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE One of the 220 patients (0.45%) with diabetes was homozygous for the HFE 845A (C282Y) mutation and 25 (11.3%) were heterozygous for the same mutation, of whom 3 (1.3%) were compound heterozygotes also carrying the HFE 187G (H63D) mutation. 10695662

2000